{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-inflammatory", "anticancer", "antiviral", "bufadienolides", "bufalin", "bufotalin", "cardiotonic steroids"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36235123", "DateCompleted": {"Year": "2022", "Month": "10", "Day": "17"}, "DateRevised": {"Year": "2022", "Month": "10", "Day": "19"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "05"}], "Language": ["eng"], "ELocationID": ["6586", "10.3390/molecules27196586"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "19", "PubDate": {"Year": "2022", "Month": "Oct", "Day": "05"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Chemistry and the Potential Antiviral, Anticancer, and Anti-Inflammatory Activities of Cardiotonic Steroids Derived from Toads.", "Abstract": {"AbstractText": ["Cardiotonic steroids (CTS) were first documented by ancient Egyptians more than 3000 years ago. Cardiotonic steroids are a group of steroid hormones that circulate in the blood of amphibians and toads and can also be extracted from natural products such as plants, herbs, and marines. It is well known that cardiotonic steroids reveal effects against congestive heart failure and atrial fibrillation; therefore, the term \"cardiotonic\" has been coined. Cardiotonic steroids are divided into two distinct groups: cardenolides (plant-derived) and bufadienolides (mainly of animal origin). Cardenolides have an unsaturated five-membered lactone ring attached to the steroid nucleus at position 17; bufadienolides have a doubly unsaturated six-membered lactone ring. Cancer is a leading cause of mortality in humans all over the world. In 2040, the global cancer load is expected to be 28.4 million cases, which would be a 47% increase from 2020. Moreover, viruses and inflammations also have a very nebative impact on human health and lead to mortality. In the current review, we focus on the chemistry, antiviral and anti-cancer activities of cardiotonic steroids from the naturally derived (toads) venom to combat these chronic devastating health problems. The databases of different research engines (Google Scholar, PubMed, Science Direct, and Sci-Finder) were screened using different combinations of the following terms: \"cardiotonic steroids\", \"anti-inflammatory\", \"antiviral\", \"anticancer\", \"toad venom\", \"bufadienolides\", and \"poison chemical composition\". Various cardiotonic steroids were isolated from diverse toad species and exhibited superior anti-inflammatory, anticancer, and antiviral activities in in vivo and in vitro models such as marinobufagenin, gammabufotalin, resibufogenin, and bufalin. These steroids are especially difficult to identify. However, several compounds and their bioactivities were identified by using different molecular and biotechnological techniques. Biotechnology is a new tool to fully or partially generate upscaled quantities of natural products, which are otherwise only available at trace amounts in organisms."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang 212013, China."}, {"Identifier": [], "Affiliation": "Pharmacognosy Group, Department of Pharmaceutical Biosciences, Biomedical Centre, Uppsala University, Box 591, SE 751 24 Uppsala, Sweden."}, {"Identifier": [], "Affiliation": "International Joint Research Laboratory of Intelligent Agriculture and Agri-Products Processing (Jiangsu Education Department), Zhenjiang 212013, China."}, {"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Science, Menoufia University, Shebin El-Kom 32512, Egypt."}], "LastName": "El-Seedi", "ForeName": "Hesham R", "Initials": "HR"}, {"Identifier": ["0000-0002-5043-9690"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department of Medicinal and Aromatic Plants, Research Institute of Medicinal and Aromatic Plants (RIMAP), Beni-Suef University, Beni-Suef 62514, Egypt."}, {"Identifier": [], "Affiliation": "School of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China."}], "LastName": "Yosri", "ForeName": "Nermeen", "Initials": "N"}, {"Identifier": ["0000-0001-8520-347X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry Division, Chemistry Department, Faculty of Science, Menoufia University, Shebin El-Koom 32512, Egypt."}, {"Identifier": [], "Affiliation": "Division of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University, Okayama 7008530, Japan."}, {"Identifier": [], "Affiliation": "Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, CA 92618, USA."}], "LastName": "El-Aarag", "ForeName": "Bishoy", "Initials": "B"}, {"Identifier": ["0000-0001-5497-6429"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zoology Department, Faculty of Science, Menoufia University, Shebin El-Kom 32512, Egypt."}], "LastName": "Mahmoud", "ForeName": "Shaymaa H", "Initials": "SH"}, {"Identifier": ["0000-0001-5747-6972"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Department, College of Pharmacy, Tanta University, Elguish Street, Tanta 31527, Egypt."}], "LastName": "Zayed", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": ["0000-0001-5872-8529"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116024, China."}], "LastName": "Du", "ForeName": "Ming", "Initials": "M"}, {"Identifier": ["0000-0002-7112-9296"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan."}], "LastName": "Saeed", "ForeName": "Aamer", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi 75270, Pakistan."}], "LastName": "Musharraf", "ForeName": "Syed G", "Initials": "SG"}, {"Identifier": ["0000-0002-7241-4910"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zoology Department, Faculty of Science, Menoufia University, Shebin El-Kom 32512, Egypt."}], "LastName": "El-Garawani", "ForeName": "Islam M", "Initials": "IM"}, {"Identifier": ["0000-0003-0820-9290"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Malacology Department, Theodor Bilharz Research Institute, Imbaba, Giza 12411, Egypt."}], "LastName": "Habib", "ForeName": "Mohamed R", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China."}], "LastName": "Tahir", "ForeName": "Haroon Elrasheid", "Initials": "HE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department of Medicinal and Aromatic Plants, Research Institute of Medicinal and Aromatic Plants (RIMAP), Beni-Suef University, Beni-Suef 62514, Egypt."}], "LastName": "Hegab", "ForeName": "Momtaz M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China."}], "LastName": "Zou", "ForeName": "Xiaobo", "Initials": "X"}, {"Identifier": ["0000-0001-6416-7457"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China."}], "LastName": "Guo", "ForeName": "Zhiming", "Initials": "Z"}, {"Identifier": ["0000-0002-2637-1681"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, 55128 Mainz, Germany."}], "LastName": "Efferth", "ForeName": "Thomas", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, SE 10691 Stockholm, Sweden."}], "LastName": "Khalifa", "ForeName": "Shaden A M", "Initials": "SAM"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Bufanolides"}, {"RegistryNumber": "0", "NameOfSubstance": "Cardenolides"}, {"RegistryNumber": "0", "NameOfSubstance": "Cardiac Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Hormones"}, {"RegistryNumber": "0", "NameOfSubstance": "Lactones"}, {"RegistryNumber": "0", "NameOfSubstance": "Poisons"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Biological Products"}, {"QualifierName": ["chemistry"], "DescriptorName": "Bufanolides"}, {"QualifierName": [], "DescriptorName": "Bufonidae"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cardenolides"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cardiac Glycosides"}, {"QualifierName": [], "DescriptorName": "Hormones"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Lactones"}, {"QualifierName": [], "DescriptorName": "Poisons"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "El-Mallakh R.S., Brar K.S., Yeruva R.R. Cardiac glycosides in human physiology and disease: Update for entomologists. Insects. 2019;10:102. doi: 10.3390/insects10040102.", "ArticleIdList": ["10.3390/insects10040102", "PMC6523104", "30974764"]}, {"Citation": "El-Bakry A.A., Hammad I.A., Galal T.M., Ghazi S.M., Rafat F.A. Polymorphism in Calotropis procera: Variation of metabolites in populations from different phytogeographical regions of Egypt. Rend. Lincei. 2014;25:461\u2013469. doi: 10.1007/s12210-014-0315-z.", "ArticleIdList": ["10.1007/s12210-014-0315-z"]}, {"Citation": "Mijatovic T., Van Quaquebeke E., Delest B., Debeir O., Darro F., Kiss R. Cardiotonic steroids on the road to anti-cancer therapy. Biochim. Biophys. Acta Rev. Cancer. 2007;1776:32\u201357. doi: 10.1016/j.bbcan.2007.06.002.", "ArticleIdList": ["10.1016/j.bbcan.2007.06.002", "17706876"]}, {"Citation": "Heasley B. Chemical Synthesis of the Cardiotonic Steroid Glycosides and Related Natural Products. Chem.-A Eur. J. 2012;18:3092\u20133120. doi: 10.1002/chem.201103733.", "ArticleIdList": ["10.1002/chem.201103733", "22354477"]}, {"Citation": "Bagrov A.Y., Shapiro J.I., Fedorova O.V. Endogenous cardiotonic steroids: Physiology, pharmacology, and novel therapeutic targets. Pharmacol. Rev. 2009;61:9\u201338. doi: 10.1124/pr.108.000711.", "ArticleIdList": ["10.1124/pr.108.000711", "PMC2763610", "19325075"]}, {"Citation": "Dvela M., Rosen H., Feldmann T., Nesher M., Lichtstein D. Diverse biological responses to different cardiotonic steroids. Pathophysiology. 2007;14:159\u2013166. doi: 10.1016/j.pathophys.2007.09.011.", "ArticleIdList": ["10.1016/j.pathophys.2007.09.011", "17964766"]}, {"Citation": "Kolmakova E.V., Haller S.T., Kennedy D.J., Isachkina A.N., Budny G.V., Frolova E.V., Piecha G., Nikitina E.R., Malhotra D., Fedorova O.V., et al. Endogenous cardiotonic steroids in chronic renal failure. Nephrol. Dial. Transplant. 2011;26:2912\u20132919. doi: 10.1093/ndt/gfq772.", "ArticleIdList": ["10.1093/ndt/gfq772", "PMC3203407", "21292813"]}, {"Citation": "Pavlovic D. The Role of Cardiotonic Steroids in the Pathogenesis of Cardiomyopathy in Chronic Kidney Disease. Nephron Clin. Pract. 2014;128:11\u201321. doi: 10.1159/000363301.", "ArticleIdList": ["10.1159/000363301", "25341357"]}, {"Citation": "Zhakeer Z., Hadeer M., Tuerxun Z., Tuerxun K. Bufalin Inhibits the Inflammatory Effects in Asthmatic Mice through the Suppression of Nuclear Factor-Kappa B Activity. Pharmacology. 2017;99:179\u2013187. doi: 10.1159/000450754.", "ArticleIdList": ["10.1159/000450754", "28049205"]}, {"Citation": "Abd El-wahed A., Yosri N., Sakr H.H., Du M., Algethami A.F.M., Zhao C., Abdelazeem A.H., Tahir H.E., Masry S.H.D., Abdel-daim M.M., et al. A Abd El-Wahed. Toxins. 2021;13:206. doi: 10.3390/toxins13030206.", "ArticleIdList": ["10.3390/toxins13030206", "PMC8000949", "33809401"]}, {"Citation": "Mortari M.R., Cunha A.O.S., Ferreira L.B., dos Santos W.F. Neurotoxins from invertebrates as anticonvulsants: From basic research to therapeutic application. Pharmacol. Ther. 2007;114:171\u2013183. doi: 10.1016/j.pharmthera.2007.01.009.", "ArticleIdList": ["10.1016/j.pharmthera.2007.01.009", "17399793"]}, {"Citation": "El-Seedi H., El-Wahed A., Yosri N., Musharraf S.G., Chen L., Moustafa M., Zou X., Al-Mousawi S., Guo Z., Khatib A. Antimicrobial properties of Apis mellifera\u2019s bee venom. Toxins. 2020;12:451. doi: 10.3390/toxins12070451.", "ArticleIdList": ["10.3390/toxins12070451", "PMC7404974", "32664544"]}, {"Citation": "Toledo R.C., Jared C. Cutaneous granular glands and amphibian venoms. Comp. Biochem. Physiol.-Part A Physiol. 1995;111:1\u201329. doi: 10.1016/0300-9629(95)98515-I.", "ArticleIdList": ["10.1016/0300-9629(95)98515-I"]}, {"Citation": "Van Bocxlaer I., Loader S.P., Roelants K., Biju S.D., Menegon M., Bossuyt F. Gradual adaptation toward a range-expansion phenotype initiated the global radiation of toads. Science. 2010;327:679\u2013682. doi: 10.1126/science.1181707.", "ArticleIdList": ["10.1126/science.1181707", "20133569"]}, {"Citation": "Clarke B.T. The natural history of amphibian skin secretions, their normal functioning and potential medical applications. Biol. Rev. Camb. Philos. Soc. 1997;72:365\u2013379. doi: 10.1017/S0006323197005045.", "ArticleIdList": ["10.1017/S0006323197005045", "9336100"]}, {"Citation": "Soumoy L., Welles M., Najem A., Krayem M., Ghanem G., Hambye S., Saussez S., Blankert B., Journe F. Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms. Biology. 2020;9:218. doi: 10.3390/biology9080218.", "ArticleIdList": ["10.3390/biology9080218", "PMC7464305", "32785105"]}, {"Citation": "Tang H.-J., Ruan L.-J., Tian H.-Y., Liang G.-P., Ye W.-C., Hughes E., Esmann M., Fedosova N.U., Chung T.-Y., Tzen J.T.C. Novel stereoselective bufadienolides reveal new insights into the requirements for Na+, K+-ATPase inhibition by cardiotonic steroids. Sci. Rep. 2016;6:29155. doi: 10.1038/srep29155.", "ArticleIdList": ["10.1038/srep29155", "PMC4932606", "27377465"]}, {"Citation": "Baldo E.C.F., Anjolette F.A.P., Arantes E.C., Baldo M.A. Toad poison and drug discovery. Toxicon. 2015;16:1\u201322."}, {"Citation": "Perry D. Proteins of parotoid gland secretions from toads of the genus Bufo. Contemp. Herpetol. 2000;3:1\u20137. doi: 10.17161/ch.vi1.11962.", "ArticleIdList": ["10.17161/ch.vi1.11962"]}, {"Citation": "Jared C., Antoniazzi M.M., Jord\u00e3o A.E.C., Silva J.R.M.C., Greven H., Rodrigues M.T. Parotoid macroglands in toad (Rhinella jimi): Their structure and functioning in passive defence. Toxicon. 2009;54:197\u2013207. doi: 10.1016/j.toxicon.2009.03.029.", "ArticleIdList": ["10.1016/j.toxicon.2009.03.029", "19374917"]}, {"Citation": "Gopalakrishnakone P., Cruz L.J., Luo S. In: Toxins and Drug Discovery. Gopalakrishnakone P., Cruz L.J., Luo S., editors. Springer; Amsterdam, The Netherlands: 2015."}, {"Citation": "de Sousa L.Q., da Concei\u00e7\u00e3o Machado K., de Carvalho Oliveira S.F., da Silva Ara\u00fajo L., dos Santos Mon\u00e7\u00e3o-Filho E., Am\u00e9lia A., Vieira-J\u00fanior G.M., Ferreira P.M.P. Bufadienolides from amphibians: A promising source of anticancer prototypes for radical innovation, apoptosis triggering and Na+/K+-ATPase inhibition. Toxicon. 2017;127:63\u201376. doi: 10.1016/j.toxicon.2017.01.004.", "ArticleIdList": ["10.1016/j.toxicon.2017.01.004", "28069354"]}, {"Citation": "Amarelle L., Lecuona E. The Antiviral Effects of Na,K-ATPase Inhibition: A Minireview. Int. J. Mol. Sci. 2018;19:2154. doi: 10.3390/ijms19082154.", "ArticleIdList": ["10.3390/ijms19082154", "PMC6121263", "30042322"]}, {"Citation": "Orellana A.M., Kinoshita P.F., Leite J.A., Kawamoto E.M., Scavone C. Cardiotonic steroids as modulators of neuroinflammation. Front. Endocrinol. 2016;7:10. doi: 10.3389/fendo.2016.00010.", "ArticleIdList": ["10.3389/fendo.2016.00010", "PMC4754428", "26909067"]}, {"Citation": "Hayes R.A., Piggott A.M., Dalle K., Capon R.J. Microbial biotransformation as a source of chemical diversity in cane toad steroid toxins. Bioorganic Med. Chem. Lett. 2009;19:1790\u20131792. doi: 10.1016/j.bmcl.2009.01.064.", "ArticleIdList": ["10.1016/j.bmcl.2009.01.064", "19216077"]}, {"Citation": "\u00dcveges B., Fera G., M\u00f3ricz \u00c1.M., Kr\u00fczselyi D., B\u00f3kony V., Hettyey A. Age- and environment-dependent changes in chemical defences of larval and post-metamorphic toads. BMC Evol. Biol. 2017;17:137. doi: 10.1186/s12862-017-0956-5.", "ArticleIdList": ["10.1186/s12862-017-0956-5", "PMC5470210", "28610604"]}, {"Citation": "B\u00f3kony V., \u00dcveges B., M\u00f3ricz \u00c1.M., Hettyey A. Competition induces increased toxin production in toad larvae without allelopathic effects on heterospecific tadpoles. Funct. Ecol. 2018;32:667\u2013675. doi: 10.1111/1365-2435.12994.", "ArticleIdList": ["10.1111/1365-2435.12994"]}, {"Citation": "B\u00f3kony V., M\u00f3ricz \u00c1.M., T\u00f3th Z., G\u00e1l Z., Kurali A., Mik\u00f3 Z., P\u00e1sztor K., Szederk\u00e9nyi M., T\u00f3th Z., Ujszegi J., et al. Variation in Chemical Defense Among Natural Populations of Common Toad, Bufo bufo, Tadpoles: The Role of Environmental Factors. J. Chem. Ecol. 2016;42:329\u2013338. doi: 10.1007/s10886-016-0690-2.", "ArticleIdList": ["10.1007/s10886-016-0690-2", "27059330"]}, {"Citation": "Chiadao C., Osuch M. V Biosynthesis of bufadienolides\u20143\u03b2-hydroxycholanates as precursors in Bufo marinus bufadienolides synthesis. Biochem. Pharmacol. 1969;18:1797\u20131802. doi: 10.1016/0006-2952(69)90273-1.", "ArticleIdList": ["10.1016/0006-2952(69)90273-1", "5811615"]}, {"Citation": "Siperstein M.D., Murray A.W., Titus E. Biosynthesis of cardiotonic sterols from cholesterol in the toad, Bufo marinus. Arch. Biochem. Biophys. 1957;67:154\u2013160. doi: 10.1016/0003-9861(57)90254-0.", "ArticleIdList": ["10.1016/0003-9861(57)90254-0", "13412129"]}, {"Citation": "Porto A.M., Baralle F.E., Gros E.G. Biosynthesis of bufadienolides in toads: III\u2014Experiments with [2-14C] mevalonic acid, [20-14C] 3\u03b2-hydroxy-5-pregnen-20-one and [20-14C] cholesterol. J. Steroid Biochem. 1972;3:11\u201317. doi: 10.1016/0022-4731(72)90006-4.", "ArticleIdList": ["10.1016/0022-4731(72)90006-4", "5072926"]}, {"Citation": "Delfino G., Nosi D., Giachi F. Secretory granule-cytoplasm relationships in serous glands of anurans: Ultrastructural evidence and possible functional role. Toxicon. 2001;39:1161\u20131171. doi: 10.1016/S0041-0101(00)00253-1.", "ArticleIdList": ["10.1016/S0041-0101(00)00253-1", "11306126"]}, {"Citation": "Duellman W., Trueb L. Biology of amphibians. Johns Hopkins University Press; Baltimore, MD, USA: 1994."}, {"Citation": "Mailho-Fontana P.L., Antoniazzi M.M., Toledo L.F., Verdade V.K., Sciani J.M., Barbaro K.C., Pimenta D.C., Rodrigues M.T., Jared C. Passive and active defense in toads: The parotoid macroglands in Rhinella marina and Rhaebo guttatus. J. Exp. Zool. Part A Ecol. Genet. Physiol. 2014;321:65\u201377. doi: 10.1002/jez.1838.", "ArticleIdList": ["10.1002/jez.1838", "24130001"]}, {"Citation": "Jin L., Quan C., Hou X., Fan S. Potential pharmacological resources: Natural bioactive compounds from marine-derived fungi. Mar. Drugs. 2016;14:76. doi: 10.3390/md14040076.", "ArticleIdList": ["10.3390/md14040076", "PMC4849080", "27110799"]}, {"Citation": "Antoniazzi M.M., Neves P.R., Mailho-Fontana P.L., Rodrigues M.T., Jared C. Morphology of the parotoid macroglands in Phyllomedusa leaf frogs. J. Zool. 2013;291:42\u201350. doi: 10.1111/jzo.12044.", "ArticleIdList": ["10.1111/jzo.12044"]}, {"Citation": "Regis-Alves E., Jared S.G.S., Maur\u00edcio B., Mailho-Fontana P.L., Antoniazzi M.M., Fleury-Curado M.C., Brodie E.D., Jared C. Structural cutaneous adaptations for defense in toad (Rhinella icterica) parotoid macroglands. Toxicon. 2017;137:128\u2013134. doi: 10.1016/j.toxicon.2017.07.022.", "ArticleIdList": ["10.1016/j.toxicon.2017.07.022", "28760510"]}, {"Citation": "Brodie E.D., Smatresk N.J. The antipredator arsenal of fire salamanders: Spraying of secretions from highly pressurized dorsal skin glands. Herpetologica. 1990;46:1\u20137."}, {"Citation": "Mailho-Fontana P.L., Antoniazzi M.M., Rodrigues I., Sciani J.M., Pimenta D.C., Brodie E.D., Rodrigues M.T., Jared C. Parotoid, radial, and tibial macroglands of the frog Odontophrynus cultripes: Differences and similarities with toads. Toxicon. 2017;129:123\u2013133. doi: 10.1016/j.toxicon.2017.02.022.", "ArticleIdList": ["10.1016/j.toxicon.2017.02.022", "28235580"]}, {"Citation": "Tempone A.G., Pimenta D.C., Lebrun I., Sartorelli P., Taniwaki N.N., de Andrade H.F., Antoniazzi M.M., Jared C. Antileishmanial and antitrypanosomal activity of bufadienolides isolated from the toad Rhinella jimi parotoid macrogland secretion. Toxicon. 2008;52:13\u201321. doi: 10.1016/j.toxicon.2008.05.008.", "ArticleIdList": ["10.1016/j.toxicon.2008.05.008", "18588907"]}, {"Citation": "Gustavo Tempone A., de Souza Carvalho Melhem M., Oliveira Prado F., Motoie G., Mitsuyoshi Hiramoto R., Maria Antoniazzi M., Fernando Baptista Haddad C., Jared C. Amphibian Secretions for Drug Discovery Studies: A Search for New Antiparasitic and Antifungal Compounds. Lett. Drug Des. Discov. 2006;4:67\u201373. doi: 10.2174/157018007778992856.", "ArticleIdList": ["10.2174/157018007778992856"]}, {"Citation": "Dmitrieva R.I., Doris P.A. Cardiotonic steroids: Potential endogenous sodium pump ligands with diverse function. Exp. Biol. Med. 2002;227:561\u2013569. doi: 10.1177/153537020222700803.", "ArticleIdList": ["10.1177/153537020222700803", "12192097"]}, {"Citation": "Ivanchina N.V., Kicha A.A., Stonik V.A. Steroid glycosides from marine organisms. Steroids. 2011;76:425\u2013454. doi: 10.1016/j.steroids.2010.12.011.", "ArticleIdList": ["10.1016/j.steroids.2010.12.011", "21194537"]}, {"Citation": "Ali M.S., Saleem M., Yamdagni R., Ali M.A. Steroid and antibacterial steroidal glycosides from marine green alga Codium iyengarii borgesen. Nat. Prod. Lett. 2002;16:407\u2013413. doi: 10.1080/10575630290034249.", "ArticleIdList": ["10.1080/10575630290034249", "12462346"]}, {"Citation": "Saikia S., Kolita B., Dutta P.P., Dutta D.J., Neipihoi, Nath S., Bordoloi M., Quan P.M., Thuy T.T., Phuong D.L., et al. Marine steroids as potential anticancer drug candidates: In silico investigation in search of inhibitors of Bcl-2 and CDK-4/Cyclin D1. Steroids. 2015;102:7\u201316. doi: 10.1016/j.steroids.2015.06.012.", "ArticleIdList": ["10.1016/j.steroids.2015.06.012", "26111591"]}, {"Citation": "Dos Santos Dias A.C., Couzinet-Mossion A., Ruiz N., Lakhdar F., Etahiri S., Bertrand S., Ory L., Roussakis C., Pouchus Y.F., Nazih E.H., et al. Steroids from marine-derived fungi: Evaluation of antiproliferative and antimicrobial activities of eburicol. Mar. Drugs. 2019;17:372. doi: 10.3390/md17060372.", "ArticleIdList": ["10.3390/md17060372", "PMC6628047", "31234456"]}, {"Citation": "El-Seedi H.R., Khalifa S.A.M., Taher E.A., Farag M.A., Saeed A., Gamal M., Hegazy M.E.F., Youssef D., Musharraf S.G., Alajlani M.M., et al. Cardenolides: Insights from chemical structure and pharmacological utility. Pharmacol. Res. 2019;141:123\u2013175. doi: 10.1016/j.phrs.2018.12.015.", "ArticleIdList": ["10.1016/j.phrs.2018.12.015", "30579976"]}, {"Citation": "Melero C.P., Medarde M., San Feliciano A. A short review on cardiotonic steroids and their aminoguanidine analogues. Molecules. 2000;5:51\u201381. doi: 10.3390/50100051.", "ArticleIdList": ["10.3390/50100051"]}, {"Citation": "Boff L., Schreiber A., da Rocha Matos A., Del Sarto J., Brunotte L., Munkert J., Ottoni F.M., Ramos G.S., Kreis W., Braga F.C., et al. Semisynthetic cardenolides acting as antiviral inhibitors of influenza A virus replication by preventing polymerase complex formation. Molecules. 2020;25:4853. doi: 10.3390/molecules25204853.", "ArticleIdList": ["10.3390/molecules25204853", "PMC7587960", "33096707"]}, {"Citation": "Offermanns S., Rosenthal W. Encyclopedia of Molecular Pharmacology. Springer Science & Business Media; Berlin/Heidelberg, Germany: 2008."}, {"Citation": "Michalak M., Michalak K., Wicha J. The synthesis of cardenolide and bufadienolide aglycones, and related steroids bearing a heterocyclic subunit. Nat. Prod. Rep. 2017;34:361\u2013410. doi: 10.1039/C6NP00107F.", "ArticleIdList": ["10.1039/C6NP00107F", "28378871"]}, {"Citation": "Cornelius F., Kanai R., Toyoshima C. A structural view on the functional importance of the sugar moiety and steroid hydroxyls of cardiotonic steroids in binding to Na,K-ATPase. J. Biol. Chem. 2013;288:6602\u20136616. doi: 10.1074/jbc.M112.442137.", "ArticleIdList": ["10.1074/jbc.M112.442137", "PMC3585100", "23341448"]}, {"Citation": "Morsy N. In: Cardiac glycosides in medicinal plants, Aromatic and Medicinal Plants\u2014Back to nature. El-Shemy H., editor. BoD\u2014Books on Demand; London, UK: 2017."}, {"Citation": "Dondoni A., Marra A. Methods for Anomeric Carbon-Linked and Fused Sugar Amino Acid Synthesis:\u2009 The Gateway to Artificial Glycopeptides. Chem. Rev. 2000;100:4395\u20134422. doi: 10.1021/cr9903003.", "ArticleIdList": ["10.1021/cr9903003", "11749352"]}, {"Citation": "K\u0159en V. Glycoscience. Springer; Berlin, Heidelberg: 2008. Glycoside vs. Aglycon: The Role of Glycosidic Residue in Biological Activity; pp. 2589\u20132644."}, {"Citation": "Gupta S.P. Quantitative structure-activity relationships of cardiotonic agents. Prog. Drug Res. 2000;55:235\u2013282.", "ArticleIdList": ["11127965"]}, {"Citation": "Yang Q., Zhou X., Zhang M., Bi L., Miao S., Cao W., Xie Y., Sun J., Tang H., Li Y., et al. Angel of human health: Current research updates in toad medicine. Am. J. Transl. Res. 2015;7:1\u201314.", "ArticleIdList": ["PMC4346519", "25755824"]}, {"Citation": "Klupczynska A., Pawlak M., Kokot Z.J., Matysiak J. Application of metabolomic tools for studying low molecular-weight fraction of animal venoms and poisons. Toxins. 2018;10:306. doi: 10.3390/toxins10080306.", "ArticleIdList": ["10.3390/toxins10080306", "PMC6116190", "30042318"]}, {"Citation": "Kamano Y., Kotake A., Hashima H., Inoue M., Morita H., Takeya K., Itokawa H., Nandachi N., Segawa T., Yukita A., et al. Structure\u2013cytotoxic activity relationship for the toad poison bufadienolides. Bioorg. Med. Chem. 1998;6:1103\u20131115. doi: 10.1016/S0968-0896(98)00067-4.", "ArticleIdList": ["10.1016/S0968-0896(98)00067-4", "9730247"]}, {"Citation": "Ye M., Qu G., Guo H., Guo D. Specific 12\u03b2-hydroxylation of cinobufagin by filamentous fungi. Appl. Environ. Microbiol. 2004;70:3521\u20133527. doi: 10.1128/AEM.70.6.3521-3527.2004.", "ArticleIdList": ["10.1128/AEM.70.6.3521-3527.2004", "PMC427727", "15184152"]}, {"Citation": "Li M., Yu X., Guo H., Sun L., Wang A., Liu Q., Wang X., Li J. Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells. Tumor Biol. 2014;35:2461\u20132471. doi: 10.1007/s13277-013-1326-6.", "ArticleIdList": ["10.1007/s13277-013-1326-6", "24218335"]}, {"Citation": "Qian L., Su H., Wang G., Li B., Shen G., Gao Q. Anti-tumor activity of bufalin by inhibiting c-MET mediated MEK/ERK and PI3K/AKT signaling pathways in gallbladder cancer. J. Cancer. 2020;11:3114\u20133123. doi: 10.7150/jca.38393.", "ArticleIdList": ["10.7150/jca.38393", "PMC7097950", "32231716"]}, {"Citation": "Su S., Dou H., Wang Z., Zhang Q. Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF-\u03b1 pathway. Basic Clin. Pharmacol. Toxicol. 2021;128:224\u2013233. doi: 10.1111/bcpt.13487.", "ArticleIdList": ["10.1111/bcpt.13487", "32905663"]}, {"Citation": "Qi J., Zulfiker A.H.M., Li C., Good D., Wei M.Q. The development of toad toxins as potential therapeutic agents. Toxins. 2018;10:336. doi: 10.3390/toxins10080336.", "ArticleIdList": ["10.3390/toxins10080336", "PMC6115759", "30127299"]}, {"Citation": "Cohen T., Williams J.D., Opperman T.J., Sanchez R., Lurain N.S., Tortorella D. Convallatoxin-Induced Reduction of Methionine Import Effectively Inhibits Human Cytomegalovirus Infection and Replication. J. Virol. 2016;90:10715\u201310727. doi: 10.1128/JVI.01050-16.", "ArticleIdList": ["10.1128/JVI.01050-16", "PMC5110156", "27654292"]}, {"Citation": "Burkard C., Verheije M.H., Haagmans B.L., van Kuppeveld F.J., Rottier P.J.M., Bosch B.-J., de Haan C.A.M. ATP1A1-Mediated Src Signaling Inhibits Coronavirus Entry into Host Cells. J. Virol. 2015;89:4434\u20134448. doi: 10.1128/JVI.03274-14.", "ArticleIdList": ["10.1128/JVI.03274-14", "PMC4442369", "25653449"]}, {"Citation": "Laird G.M., Eisele E.E., Rabi S.A., Nikolaeva D., Siliciano R.F. A novel cell-based high-throughput screen for inhibitors of HIV-1 gene expression and budding identifies the cardiac glycosides. J. Antimicrob. Chemother. 2014;69:988\u2013994. doi: 10.1093/jac/dkt471.", "ArticleIdList": ["10.1093/jac/dkt471", "PMC3956374", "24275119"]}, {"Citation": "Dodson A.W., Taylor T.J., Knipe D.M., Coen D.M. Inhibitors of the sodium potassium ATPase that impair herpes simplex virus replication identified via a chemical screening approach. Virology. 2007;366:340\u2013348. doi: 10.1016/j.virol.2007.05.001.", "ArticleIdList": ["10.1016/j.virol.2007.05.001", "PMC2099250", "17544048"]}, {"Citation": "Zhang Z.R., Zhang Y.N., Li X.D., Zhang H.Q., Xiao S.Q., Deng F., Yuan Z.M., Ye H.Q., Zhang B. A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2. Signal Transduct. Target. Ther. 2020;5:218. doi: 10.1038/s41392-020-00343-z.", "ArticleIdList": ["10.1038/s41392-020-00343-z", "PMC7532339", "33011739"]}, {"Citation": "Jin Y.-H., Jeon S., Lee J., Kim S., Jang M.S., Park C.M., Song J.H., Kim H.R., Kwon S. Broad Spectrum Antiviral Properties of Cardiotonic Steroids Used as Potential Therapeutics for Emerging Coronavirus Infections. Pharmaceutics. 2021;13:1839. doi: 10.3390/pharmaceutics13111839.", "ArticleIdList": ["10.3390/pharmaceutics13111839", "PMC8618917", "34834252"]}, {"Citation": "Cui X., Inagaki Y., Xu H., Wang D., Qi F., Kokudo N., Fang D., Tang W. Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 Cells. Biol. Pharm. Bull. 2010;33:1728\u20131732. doi: 10.1248/bpb.33.1728.", "ArticleIdList": ["10.1248/bpb.33.1728", "20930383"]}, {"Citation": "Chen J., Xu L., Sun S., Zhang H., Ma T., Su W., Jiang C. Identification of cinobufagin and resibufogenin as inhibitors of enterovirus 71 infection. Chem. Res. Chinese Univ. 2014;30:953\u2013958. doi: 10.1007/s40242-014-4133-8.", "ArticleIdList": ["10.1007/s40242-014-4133-8"]}, {"Citation": "Wong R.W., Lingwood C.A., Ostrowski M.A., Cabral T., Cochrane A. Cardiac glycoside/aglycones inhibit HIV-1 gene expression by a mechanism requiring MEK1/2-ERK1/2 signaling. Sci. Rep. 2018;8:850. doi: 10.1038/s41598-018-19298-x.", "ArticleIdList": ["10.1038/s41598-018-19298-x", "PMC5770468", "29339801"]}, {"Citation": "Horisberger J.D. Recent insights into the structure and mechanism of the sodium pump. Physiology. 2004;19:377\u2013387. doi: 10.1152/physiol.00013.2004.", "ArticleIdList": ["10.1152/physiol.00013.2004", "15546856"]}, {"Citation": "Rahimtoola S.H., Tak T. The use of digitalis in heart failure. Curr. Probl. Cardiol. 1996;21:781\u2013853. doi: 10.1016/S0146-2806(96)80001-6.", "ArticleIdList": ["10.1016/S0146-2806(96)80001-6", "8968683"]}, {"Citation": "Weidemann H. NA/K-ATPase, endogenous digitalis-like compounds and cancer development\u2014A hypothesis. Front. Biosci. 2005;10:2165\u20132176. doi: 10.2741/1688.", "ArticleIdList": ["10.2741/1688", "15970485"]}, {"Citation": "Gonta-Grabiec K., Rossowski W., Szumiel I. Properties of Na+/K+ ATPase and alkaline phosphatase alter during spontaneous and radiation-induced leukemogenesis in mice. Neoplasma. 1986;33:141\u2013155.", "ArticleIdList": ["3012384"]}, {"Citation": "Kaplan J.G. Membrane cation transport and the control of proliferation of mammalian cells. Annu. Rev. Physiol. 1978;40:19\u201341. doi: 10.1146/annurev.ph.40.030178.000315.", "ArticleIdList": ["10.1146/annurev.ph.40.030178.000315", "147644"]}, {"Citation": "Liu S.H., Lin C.H., Hung S.K., Chou J.H., Chi C.W., Fu S.L. Fisetin inhibits lipopolysaccharide-induced macrophage activation and dendritic cell maturation. J. Agric. Food Chem. 2010;58:10831\u201310839. doi: 10.1021/jf1017093.", "ArticleIdList": ["10.1021/jf1017093", "20923145"]}, {"Citation": "Shen S.S., Hamamoto S.T., Bern H.A., Steinhardt R.A. Alteration of Sodium Transport in Mouse Mammary Epithelium Associated with Neoplastic Transformation. Cancer Res. 1978;38:1356\u20131361.", "ArticleIdList": ["205364"]}, {"Citation": "Huang L., Li H., Xie Z. Ouabain-induced hypertrophy in cultured cardiac myocytes is accompanied by changes in expression of several late response genes. J. Mol. Cell. Cardiol. 1997;29:429\u2013437. doi: 10.1006/jmcc.1996.0320.", "ArticleIdList": ["10.1006/jmcc.1996.0320", "9140803"]}, {"Citation": "Davies R.J., Sandle G.I., Thompson S.M. Inhibition of the Na+,K(+)-ATPase pump during induction of experimental colon cancer. Cancer Biochem. Biophys. 1991;12:81\u201394.", "ArticleIdList": ["1662999"]}, {"Citation": "Kometiani P., Li J., Gnudi L., Kahn B.B., Askari A., Xie Z. Multiple signal transduction pathways link Na+/K+-ATPase to growth- related genes in cardiac myocytes: The roles of Ras and mitogen-activated protein kinases. J. Biol. Chem. 1998;273:15249\u201315256. doi: 10.1074/jbc.273.24.15249.", "ArticleIdList": ["10.1074/jbc.273.24.15249", "9614140"]}, {"Citation": "Xie Z., Kometiani P., Liu J., Li J., Shapiro J.I., Askari A. Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J. Biol. Chem. 1999;274:19323\u201319328. doi: 10.1074/jbc.274.27.19323.", "ArticleIdList": ["10.1074/jbc.274.27.19323", "10383443"]}, {"Citation": "Haas M., Wang H., Tian J., Xie Z. Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J. Biol. Chem. 2002;277:18694\u201318702. doi: 10.1074/jbc.M111357200.", "ArticleIdList": ["10.1074/jbc.M111357200", "11907028"]}, {"Citation": "Cerella C., Dicato M., Diederich M. Assembling the puzzle of anti-cancer mechanisms triggered by cardiac glycosides. Mitochondrion. 2013;13:225\u2013234. doi: 10.1016/j.mito.2012.06.003.", "ArticleIdList": ["10.1016/j.mito.2012.06.003", "22735572"]}, {"Citation": "Menger L., Vacchelli E., Kepp O., Eggermont A., Tartour E., Zitvogel L., Kroemer G., Galluzzi L. Trial watch: Cardiac glycosides and cancer therapy. Oncoimmunology. 2013;2:e23082. doi: 10.4161/onci.23082.", "ArticleIdList": ["10.4161/onci.23082", "PMC3601180", "23525565"]}, {"Citation": "Haas M., Askari A., Xie Z. Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J. Biol. Chem. 2000;275:27832\u201327837. doi: 10.1074/jbc.M002951200.", "ArticleIdList": ["10.1074/jbc.M002951200", "10874030"]}, {"Citation": "Mekhail T., Kaur H., Ganapathi R., Budd G.T., Elson P., Bukowski R.M. Phase 1 trial of AnvirzelTM in patients with refractory solid tumors. Invest. New Drugs. 2006;24:423\u2013427. doi: 10.1007/s10637-006-7772-x.", "ArticleIdList": ["10.1007/s10637-006-7772-x", "16763787"]}, {"Citation": "Feng B., Guo Y.W., Huang C.G., Li L., Chen R.H., Jiao B.H. 2\u2032-epi-2\u2032-O-Acetylthevetin B extracted from seeds of Cerbera manghas L. induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Chem. Biol. Interact. 2010;183:142\u2013153. doi: 10.1016/j.cbi.2009.10.012.", "ArticleIdList": ["10.1016/j.cbi.2009.10.012", "19874809"]}, {"Citation": "Varbanov H.P., Kuttler F., Banfi D., Turcatti G., Dyson P.J. Repositioning approved drugs for the treatment of problematic cancers using a screening approach. PLoS ONE. 2017;12:e0171052. doi: 10.1371/journal.pone.0171052.", "ArticleIdList": ["10.1371/journal.pone.0171052", "PMC5293254", "28166232"]}, {"Citation": "Liang M., Tian J., Liu L., Pierre S., Liu J., Shapiro J., Xie Z.J. Identification of a pool of non-pumping Na/K-ATPase. J. Biol. Chem. 2007;282:10585\u201310593. doi: 10.1074/jbc.M609181200.", "ArticleIdList": ["10.1074/jbc.M609181200", "17296611"]}, {"Citation": "Mijatovic T., Roland I., Van Quaquebeke E., Nilsson B., Mathieu A., Van Vynckt F., Darro F., Blanco G., Facchini V., Kiss R. The \u03b11 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J. Pathol. 2007;212:170\u2013179. doi: 10.1002/path.2172.", "ArticleIdList": ["10.1002/path.2172", "17471453"]}, {"Citation": "Mathieu V., Pirker C., Martin de Lassalle E., Vernier M., Mijatovic T., DeNeve N., Gaussin J.F., Dehoux M., Lefranc F., Berger W., et al. The sodium pump \u03b11 sub-unit: A disease progression-related target for metastatic melanoma treatment. J. Cell. Mol. Med. 2009;13:3960\u20133972. doi: 10.1111/j.1582-4934.2009.00708.x.", "ArticleIdList": ["10.1111/j.1582-4934.2009.00708.x", "PMC4516543", "19243476"]}, {"Citation": "Lefranc F., Kiss R. The sodium pump \u03b11 subunit as a potential target to combat apoptosis-resistant glioblastomas. Neoplasia. 2008;10:198\u2013206. doi: 10.1593/neo.07928.", "ArticleIdList": ["10.1593/neo.07928", "PMC2259449", "18323016"]}, {"Citation": "Kim N., Yim H.Y., He N., Lee C.J., Kim J.H., Choi J.S., Lee H.S., Kim S., Jeong E., Song M., et al. Cardiac glycosides display selective efficacy for STK11 mutant lung cancer. Sci. Rep. 2016;6:29721. doi: 10.1038/srep29721.", "ArticleIdList": ["10.1038/srep29721", "PMC4949473", "27431571"]}, {"Citation": "Yang Y., Cai X., Yang J., Sun X., Hu C., Yan Z., Xu X., Lu W., Wang X., Cao P. Chemoprevention of dietary digitoflavone on colitis-associated colon tumorigenesis through inducing Nrf2 signaling pathway and inhibition of inflammation. Mol. Cancer. 2014;13:48. doi: 10.1186/1476-4598-13-48.", "ArticleIdList": ["10.1186/1476-4598-13-48", "PMC3973863", "24602443"]}, {"Citation": "Wang Y., Qiu Q., Shen J.J., Li D.D., Jiang X.J., Si S.Y., Shao R.G., Wang Z. Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways. Int. J. Biochem. Cell Biol. 2012;44:1813\u20131824. doi: 10.1016/j.biocel.2012.06.028.", "ArticleIdList": ["10.1016/j.biocel.2012.06.028", "22750415"]}, {"Citation": "Juncker T., Schumacher M., Dicato M., Diederich M. UNBS1450 from Calotropis procera as a regulator of signaling pathways involved in proliferation and cell death. Biochem. Pharmacol. 2009;78:1\u201310. doi: 10.1016/j.bcp.2009.01.018.", "ArticleIdList": ["10.1016/j.bcp.2009.01.018", "19447218"]}, {"Citation": "Pongrakhananon V., Chunhacha P., Chanvorachote P. Ouabain Suppresses the Migratory Behavior of Lung Cancer Cells. PLoS ONE. 2013;8:e68623. doi: 10.1371/journal.pone.0068623.", "ArticleIdList": ["10.1371/journal.pone.0068623", "PMC3707866", "23874694"]}, {"Citation": "Schneider N.F.Z., Geller F.C., Persich L., Marostica L.L., P\u00e1dua R.M., Kreis W., Braga F.C., Sim\u00f5es C.M.O. Inhibition of cell proliferation, invasion and migration by the cardenolides digitoxigenin monodigitoxoside and convallatoxin in human lung cancer cell line. Nat. Prod. Res. 2016;30:1327\u20131331. doi: 10.1080/14786419.2015.1055265.", "ArticleIdList": ["10.1080/14786419.2015.1055265", "26252521"]}, {"Citation": "Yang S.Y., Kim N.H., Cho Y.S., Lee H., Kwon H.J. Convallatoxin, a dual inducer of autophagy and apoptosis, inhibits angiogenesis in vitro and in vivo. PLoS ONE. 2014;9:e91094. doi: 10.1371/journal.pone.0091094.", "ArticleIdList": ["10.1371/journal.pone.0091094", "PMC3963847", "24663328"]}, {"Citation": "Watabe M., Masuda Y., Nakajo S., Yoshida T., Kuroiwa Y., Nakaya K. The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells. J. Biol. Chem. 1996;271:14067\u201314073. doi: 10.1074/jbc.271.24.14067.", "ArticleIdList": ["10.1074/jbc.271.24.14067", "8662906"]}, {"Citation": "Kurosawa M., Numazawa S., Tani Y., Yoshida T. ERK signaling mediates the induction of inflammatory cytokines by bufalin in human monocytic cells. Am. J. Physiol.-Cell Physiol. 2000;278:C500\u2013C508. doi: 10.1152/ajpcell.2000.278.3.C500.", "ArticleIdList": ["10.1152/ajpcell.2000.278.3.C500", "10712238"]}, {"Citation": "Jiang Y., Zhang Y., Luan J., Duan H., Zhang F., Yagasaki K., Zhang G. Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action. Cytotechnology. 2010;62:573\u2013583. doi: 10.1007/s10616-010-9310-0.", "ArticleIdList": ["10.1007/s10616-010-9310-0", "PMC2995143", "20963488"]}, {"Citation": "Watabe M., Ito K., Masuda Y., Nakajo S., Nakaya K. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene. 1998;16:779\u2013787. doi: 10.1038/sj.onc.1201592.", "ArticleIdList": ["10.1038/sj.onc.1201592", "9488042"]}, {"Citation": "Zhang J., Sha J., Zhou Y., Han K., Wang Y., Su Y., Yin X., Hu H., Yao Y. Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221. Evid.-Based Complement. Altern. Med. 2016;2016:7319464. doi: 10.1155/2016/7319464.", "ArticleIdList": ["10.1155/2016/7319464", "PMC5198087", "28074104"]}, {"Citation": "Yu C.H., Kan S.F., Pu H.F., Jea Chien E., Wang P.S. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells. Cancer Sci. 2008;99:2467\u20132476. doi: 10.1111/j.1349-7006.2008.00966.x.", "ArticleIdList": ["10.1111/j.1349-7006.2008.00966.x", "19037992"]}, {"Citation": "Yamada K., Hino K.I., Tomoyasu S., Honma Y., Tsuruoka N. Enhancement by bufalin of retinoic acid-induced differentiation of acute promyelocytic leukemia cells in primary culture. Leuk. Res. 1998;22:589\u2013595. doi: 10.1016/S0145-2126(98)00044-7.", "ArticleIdList": ["10.1016/S0145-2126(98)00044-7", "9680108"]}, {"Citation": "Qi F., Inagaki Y., Gao B., Cui X., Xu H., Kokudo N., Li A., Tang W. Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways. Cancer Sci. 2011;102:951\u2013958. doi: 10.1111/j.1349-7006.2011.01900.x.", "ArticleIdList": ["10.1111/j.1349-7006.2011.01900.x", "21288283"]}, {"Citation": "Chen X.Y., Xu R.C., Chen L. Apoptosis of gastric cancer cells induced by bufalin. Basic Med. 2000;5:50\u201354."}, {"Citation": "Masuda Y., Kawazoe N., Nakajo S., Yoshida T., Kuroiwa Y., Nakaya K. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk. Res. 1995;19:549\u2013556. doi: 10.1016/0145-2126(95)00031-I.", "ArticleIdList": ["10.1016/0145-2126(95)00031-I", "7658701"]}, {"Citation": "Watabe M., Kawazoe N., Masuda Y., Nakajo S., Nakaya K. Bcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogenactivated protein kinase activation in human leukemia U937 cells. Cancer Res. 1997;57:3097\u20133100.", "ArticleIdList": ["9242431"]}, {"Citation": "Han K.Q., Huang G., Gu W., Su Y.H., Huang X.Q., Ling C.Q. Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice. World J. Gastroenterol. 2007;13:3374\u20133379. doi: 10.3748/wjg.v13.i24.3374.", "ArticleIdList": ["10.3748/wjg.v13.i24.3374", "PMC4172720", "17659679"]}, {"Citation": "Zhang J., Zhou X., Zhou Y., Wang Y., Qian B., He A., Shen Z., Hu H., Yao Y. Bufalin suppresses the migration and invasion of prostate cancer cells through HOTAIR, the sponge of miR-520b. Acta Pharmacol. Sin. 2019;40:1228\u20131236. doi: 10.1038/s41401-019-0234-8.", "ArticleIdList": ["10.1038/s41401-019-0234-8", "PMC6786369", "31028291"]}, {"Citation": "Li Y., Tian X., Liu X., Gong P. Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways. Carcinogenesis. 2018;39:700\u2013707. doi: 10.1093/carcin/bgy039.", "ArticleIdList": ["10.1093/carcin/bgy039", "29546393"]}, {"Citation": "Zhen S., Hua L., Liu Y.-H., Wan D.-Y., Luo W.-J. Bufalin attenuates the proliferation of breast cancer MCF-7 cells in vitro and in vivo by inhibiting the PI3K/Akt pathway. Int. J. Clin. Exp. Med. I. 2016;3:10297\u201310303."}, {"Citation": "Nakata M., Mori S., Kamoshida Y., Kawaguchi S., Fujita-Yamaguchi Y., Gao B., Tang W. Toad skin extract cinobufatini inhibits migration of human breast carcinoma MDA-MB-231 cells into a model stromal tissue. Biosci. Trends. 2015;9:266\u2013269. doi: 10.5582/bst.2015.01109.", "ArticleIdList": ["10.5582/bst.2015.01109", "26355227"]}, {"Citation": "Dong Y., Yin S., Li J., Jiang C., Ye M., Hu H. Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway. Apoptosis. 2011;16:394\u2013403. doi: 10.1007/s10495-011-0573-5.", "ArticleIdList": ["10.1007/s10495-011-0573-5", "21259053"]}, {"Citation": "Liu M., Feng L.X., Sun P., Liu W., Wu W.Y., Jiang B.H., Yang M., Hu L.H., Guo D.A., Liu X. A novel bufalin derivative exhibited stronger apoptosis-inducing effect than bufalin in A549 lung cancer cells and lower acute toxicity in mice. PLoS ONE. 2016;11:e0159789. doi: 10.1371/journal.pone.0159789.", "ArticleIdList": ["10.1371/journal.pone.0159789", "PMC4961401", "27459387"]}, {"Citation": "Zhu Z., Sun H., Ma G., Wang Z., Li E., Liu Y., Liu Y. Bufalin induces lung cancer cell apoptosis via the inhibition of PI3K/Akt pathway. Int. J. Mol. Sci. 2012;13:2025\u20132035. doi: 10.3390/ijms13022025.", "ArticleIdList": ["10.3390/ijms13022025", "PMC3292004", "22408435"]}, {"Citation": "Pan Z., Xie Y., Bai J., Lin Q., Cui X., Zhang N. Bufalin suppresses colorectal cancer cell growth through promoting autophagy: In vivo and in vitro. RSC Adv. 2018;8:38910\u201338918. doi: 10.1039/C8RA06566G.", "ArticleIdList": ["10.1039/C8RA06566G", "PMC9090649", "35558312"]}, {"Citation": "Zhang N., Xie Y., Tai Y., Gao Y., Guo W., Yu W., Li J., Feng X., Hao J., Gao Y., et al. Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4. Cell. Physiol. Biochem. 2016;40:1559\u20131569. doi: 10.1159/000453206.", "ArticleIdList": ["10.1159/000453206", "27997899"]}, {"Citation": "Yuan Z.T., Shi X.J., Yuan Y.X., Qiu Y.Y., Zou Y., Liu C., Yu H., He X., Xu K., Yin P.H. Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer. Oncotarget. 2017;8:48012\u201348026. doi: 10.18632/oncotarget.18225.", "ArticleIdList": ["10.18632/oncotarget.18225", "PMC5564622", "28624793"]}, {"Citation": "Qi H.Y., Qu X.J., Liu J., Hou K.Z., Fan Y.B., Che X.F., Liu Y.P. Bufalin induces protective autophagy by Cbl-b regulating mTOR and ERK signaling pathways in gastric cancer cells. Cell Biol. Int. 2019;43:33\u201343. doi: 10.1002/cbin.11076.", "ArticleIdList": ["10.1002/cbin.11076", "30468278"]}, {"Citation": "Zhao H., Zhao D., Tan G., Liu Y., Zhuang L., Liu T. Bufalin promotes apoptosis of gastric cancer by down-regulation of miR-298 targeting bax. Int. J. Clin. Exp. Med. 2015;8:3420.", "ArticleIdList": ["PMC4443066", "26064232"]}, {"Citation": "Miao Q., Bi L.L., Li X., Miao S., Zhang J., Zhang S., Yang Q., Xie Y.H., Zhang J., Wang S.W. Anticancer effects of bufalin on human hepatocellular carcinoma HepG2 Cells: Roles of apoptosis and autophagy. Int. J. Mol. Sci. 2013;14:1370\u20131382. doi: 10.3390/ijms14011370.", "ArticleIdList": ["10.3390/ijms14011370", "PMC3565325", "23344047"]}, {"Citation": "Schoner W. Endogenous cardiac glycosides, a new class of steroid hormones. Eur. J. Biochem. 2002;269:2440\u20132448. doi: 10.1046/j.1432-1033.2002.02911.x.", "ArticleIdList": ["10.1046/j.1432-1033.2002.02911.x", "12027881"]}, {"Citation": "Schoner W., Scheiner-Bobis G. Endogenous cardiac glycosides: Hormones using the sodium pump as signal transducer. Semin. Nephrol. 2005;25:343\u2013351. doi: 10.1016/j.semnephrol.2005.03.010.", "ArticleIdList": ["10.1016/j.semnephrol.2005.03.010", "16139690"]}, {"Citation": "Schoner W., Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: Their roles in hypertension, salt metabolism, and cell growth. Am. J. Physiol.-Cell Physiol. 2007;293:C509\u2013C536. doi: 10.1152/ajpcell.00098.2007.", "ArticleIdList": ["10.1152/ajpcell.00098.2007", "17494630"]}, {"Citation": "Fedorova O.V., Talan M.I., Agalakova N.I., Lakatta E.G., Bagrov A.Y. Endogenous ligand of \u03b11 sodium pump, marinobufagenin, is a novel mediator of sodium chloride-dependent hypertension. Circulation. 2002;105:1122\u20131127. doi: 10.1161/hc0902.104710.", "ArticleIdList": ["10.1161/hc0902.104710", "11877366"]}, {"Citation": "Uddin M.N., Allen S.R., Jones R.O., Zawieja D.C., Kuehl T.J. Pathogenesis of pre-eclampsia: Marinobufagenin and angiogenic imbalance as biomarkers of the syndrome. Transl. Res. 2012;160:99\u2013113. doi: 10.1016/j.trsl.2012.01.005.", "ArticleIdList": ["10.1016/j.trsl.2012.01.005", "22683369"]}, {"Citation": "Puschett J.B., Agunanne E., Uddin M.N. Marinobufagenin, resibufogenin and preeclampsia. Biochim. Biophys. Acta-Mol. Basis Dis. 2010;1802:1246\u20131253. doi: 10.1016/j.bbadis.2010.02.005.", "ArticleIdList": ["10.1016/j.bbadis.2010.02.005", "20167272"]}, {"Citation": "Bagrov A.Y., Fedorova O.V., Dmitrieva R.I., Howald W.N., Hunter A.P., Kuznetsova E.A., Shpen V.M. Characterization of a urinary bufodienolide Na+, K+-ATPase inhibitor in patients after acute myocardial infarction. Hypertension. 1998;31:1097\u20131103. doi: 10.1161/01.HYP.31.5.1097.", "ArticleIdList": ["10.1161/01.HYP.31.5.1097", "9576120"]}, {"Citation": "Bagrov A.Y., Roukoyatkina N.I., Pinaev A.G., Dmitrieva R.I., Fedorova O.V. Effects of two endogenous Na+, K+-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta. Eur. J. Pharmacol. 1995;274:151\u2013158. doi: 10.1016/0014-2999(94)00735-P.", "ArticleIdList": ["10.1016/0014-2999(94)00735-P", "7768267"]}, {"Citation": "Fedorova O.V., Doris P.A., Bagrov A.Y. Endogenous marinobufagenin-like factor in acute plasma volume expansion. Clin. Exp. Hypertens. 1998;20:581\u2013591. doi: 10.3109/10641969809053236.", "ArticleIdList": ["10.3109/10641969809053236", "9682914"]}, {"Citation": "Bagrov A.Y., Fedorova O.V., Dmitriev R.I., French A.W., Anderson D.E. Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs. Cardiovasc. Res. 1996;31:296\u2013305. doi: 10.1016/S0008-6363(95)00208-1.", "ArticleIdList": ["10.1016/S0008-6363(95)00208-1", "8730407"]}, {"Citation": "Hauck C., Frishman W.H. Systemic hypertension: The roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin. Cardiol. Rev. 2012;20:130\u2013138. doi: 10.1097/CRD.0b013e31823c835c.", "ArticleIdList": ["10.1097/CRD.0b013e31823c835c", "22183064"]}, {"Citation": "Gonick H.C., Ding Y., Vaziri N.D., Bagrov A.Y., Fedorova O.V. Simultaneous Measurement of Marinobufagenin, Ouabain, and Hypertension-associated Protein In Various Disease States. Clin. Exp. Hypertens. 1998;20:617\u2013627. doi: 10.3109/10641969809053240.", "ArticleIdList": ["10.3109/10641969809053240", "9682918"]}, {"Citation": "Lopatin D.A., Ailamazian E.K., Dmitrieva R.I., Shpen V.M., Fedorova O.V., Doris P.A., Bagrov A.Y. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J. Hypertens. 1999;17:1179\u20131187. doi: 10.1097/00004872-199917080-00018.", "ArticleIdList": ["10.1097/00004872-199917080-00018", "10466474"]}, {"Citation": "Lan Y.L., Wang X., Lou J.C., Xing J.S., Zou S., Yu Z.L., Ma X.C., Wang H., Zhang B. Marinobufagenin inhibits glioma growth through sodium pump \u03b11 subunit and ERK signaling-mediated mitochondrial apoptotic pathway. Cancer Med. 2018;7:2034\u20132047. doi: 10.1002/cam4.1469.", "ArticleIdList": ["10.1002/cam4.1469", "PMC5943480", "29582577"]}, {"Citation": "Chu Q., Xu H., Gao M., Guan X., Liu H., Deng S., Huo X., Liu K., Tian Y., Ma X. Liver-targeting resibufogenin-loaded poly(Lactic-co-glycolic acid)-D-\u03b1-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy. Int. J. Nanomed. 2016;11:449\u2013463.", "ArticleIdList": ["PMC4734807", "26869788"]}, {"Citation": "Lu Z., Xu A., Yuan X., Chen K., Wang L., Guo T. Anticancer effect of resibufogenin on gastric carcinoma cells through the phosphoinositide 3-kinase/protein kinase B/glycogen synthase kinase 3\u03b2 signaling pathway. Oncol. Lett. 2018;16:3297\u20133302. doi: 10.3892/ol.2018.8979.", "ArticleIdList": ["10.3892/ol.2018.8979", "PMC6096243", "30127928"]}, {"Citation": "Han Q., Ma Y., Wang H., Dai Y., Chen C., Liu Y., Jing L., Sun X. Resibufogenin suppresses colorectal cancer growth and metastasis through RIP3-mediated necroptosis. J. Transl. Med. 2018;16:201. doi: 10.1186/s12967-018-1580-x.", "ArticleIdList": ["10.1186/s12967-018-1580-x", "PMC6053767", "30029665"]}, {"Citation": "Liu L., Liu Y., Liu X., Zhang N., Mao G., Zeng Q., Yin M., Song D., Deng H. Resibufogenin suppresses transforming growth factor-\u03b2-activated kinase 1-mediated nuclear factor-\u03baB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3. Cancer Sci. 2018;109:3611\u20133622. doi: 10.1111/cas.13788.", "ArticleIdList": ["10.1111/cas.13788", "PMC6215888", "30168902"]}, {"Citation": "Zhang D.M., Liu J.S., Deng L.J., Chen M.F., Yiu A., Cao H.H., Tian H.Y., Fung K.P., Kurihara H., Pan J.X., et al. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis. 2013;34:1331\u20131342. doi: 10.1093/carcin/bgt060.", "ArticleIdList": ["10.1093/carcin/bgt060", "23393227"]}, {"Citation": "Wu J.-H., Cao Y.-T., Pan H.-Y., Wang L.-H. Identification of Antitumor Constituents in Toad Venom by Spectrum-Effect Relationship Analysis and Investigation on Its Pharmacologic Mechanism. Molecules. 2020;25:4269. doi: 10.3390/molecules25184269.", "ArticleIdList": ["10.3390/molecules25184269", "PMC7571126", "32961837"]}, {"Citation": "Zhao J., Zhang Q., Zou G., Gao G., Yue Q. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKK\u03b2/NF\u03baB signal cascade. J. Ethnopharmacol. 2020;250:112492. doi: 10.1016/j.jep.2019.112492.", "ArticleIdList": ["10.1016/j.jep.2019.112492", "31866511"]}, {"Citation": "Zhang D.M., Liu J.S., Tang M.K., Yiu A., Cao H.H., Jiang L., Yuet-Wa Chan J., Tian H.Y., Fung K.P., Ye W.C. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis. Eur. J. Pharmacol. 2012;692:19\u201328. doi: 10.1016/j.ejphar.2012.06.045.", "ArticleIdList": ["10.1016/j.ejphar.2012.06.045", "22841670"]}, {"Citation": "Wei X., He J., Gao B., Han L., Mao Y., Zhao H., Si N., Wang H., Yang J., Bian B. Hellebrigenin anti-pancreatic cancer effects based on apoptosis and autophage. PeerJ. 2020;2020:e9011. doi: 10.7717/peerj.9011.", "ArticleIdList": ["10.7717/peerj.9011", "PMC7213012", "32426183"]}, {"Citation": "Deng L.-J., Hu L.-P., Peng Q.-L., Yang X.-L., Bai L.-L., Yiu A., Li Y., Tian H.-Y., Ye W.-C., Zhang D.-M. Hellebrigenin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt. Chem. Biol. Interact. 2014;219:184\u2013194. doi: 10.1016/j.cbi.2014.06.003.", "ArticleIdList": ["10.1016/j.cbi.2014.06.003", "24954031"]}, {"Citation": "Yu Z., Guo W., Ma X., Zhang B., Dong P., Huang L., Wang X., Wang C., Huo X., Yu W. Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKK\u03b2/NF-\u03baB signaling pathway in lung cancer cells. Mol. Cancer. 2014;13:203. doi: 10.1186/1476-4598-13-203.", "ArticleIdList": ["10.1186/1476-4598-13-203", "PMC4161895", "25175164"]}, {"Citation": "Rong X., Ni W., Liu Y., Wen J., Qian C., Sun L., Wang J. Bufalin, a bioactive component of the Chinese medicine Chansu, inhibits inflammation and invasion of human rheumatoid arthritis fibroblast-like synoviocytes. Inflammation. 2014;37:1050\u20131058. doi: 10.1007/s10753-014-9828-y.", "ArticleIdList": ["10.1007/s10753-014-9828-y", "24515724"]}, {"Citation": "Yang Q., Huang W., Jozwik C., Lin Y., Glasman M., Caohuy H., Srivastava M., Esposito D., Gillette W., Hartley J., et al. Cardiac glycosides inhibit TNF-\u03b1/NF-\u03baB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Proc. Natl. Acad. Sci. USA. 2005;102:9631\u20139636. doi: 10.1073/pnas.0504097102.", "ArticleIdList": ["10.1073/pnas.0504097102", "PMC1160519", "15983368"]}, {"Citation": "Carvalho D.C.M., Cavalcante-Silva L.H.A., De A Lima \u00c9., Galv\u00e3o J.G.F.M., De A Alves A.K., Feij\u00f3 P.R.O., Quintas L.E.M., Rodrigues-Mascarenhas S. Marinobufagenin inhibits neutrophil migration and proinflammatory cytokines. J. Immunol. Res. 2019;2019:1094520. doi: 10.1155/2019/1094520.", "ArticleIdList": ["10.1155/2019/1094520", "PMC6545758", "31236418"]}, {"Citation": "Qi F., Li A., Inagaki Y., Kokudo N., Tamura S., Nakata M., Tang W. Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. Int. Immunopharmacol. 2011;11:342\u2013349. doi: 10.1016/j.intimp.2010.12.007.", "ArticleIdList": ["10.1016/j.intimp.2010.12.007", "21185919"]}, {"Citation": "Wen L., Huang Y., Xie X., Huang W., Yin J., Lin W., Jia Q., Zeng W. Anti-inflammatory and antinociceptive activities of bufalin in rodents. Mediators Inflamm. 2014;2014:171839. doi: 10.1155/2014/171839.", "ArticleIdList": ["10.1155/2014/171839", "PMC3955582", "24719521"]}, {"Citation": "Ye J., Chen S., Maniatis T. Cardiac glycosides are potent inhibitors of interferon-\u03b2 gene expression. Nat. Chem. Biol. 2010;7:25\u201333. doi: 10.1038/nchembio.476.", "ArticleIdList": ["10.1038/nchembio.476", "PMC3076628", "21076398"]}, {"Citation": "Xie X.B., Yin J.Q., Wen L.L., Gao Z.H., Zou C.Y., Wang J., Huang G., Tang Q.L., Colombo C., He W.L., et al. Critical Role of Heat Shock Protein 27 in Bufalin-Induced Apoptosis in Human Osteosarcomas: A Proteomic-Based Research. PLoS ONE. 2012;7:e47375. doi: 10.1371/journal.pone.0047375.", "ArticleIdList": ["10.1371/journal.pone.0047375", "PMC3473020", "23091618"]}, {"Citation": "Rahman A., Fazal F. Blocking NF-kB: An inflammatory issue. Proc. Am. Thorac. Soc. 2011;8:497\u2013503. doi: 10.1513/pats.201101-009MW.", "ArticleIdList": ["10.1513/pats.201101-009MW", "PMC3359076", "22052926"]}, {"Citation": "Ihenetu K., Espinosa R., De Leon R., Planas G., Perez-Pinero A., Waldbeser L. Digoxin and digoxin-like immunoreactive factors (DLIF) modulate the release of pro-inflammatory cytokines. Inflamm. Res. 2008;57:519\u2013523. doi: 10.1007/s00011-008-7249-9.", "ArticleIdList": ["10.1007/s00011-008-7249-9", "19109744"]}, {"Citation": "Jacob P.L., Leite J.A., Alves A.K.A., Rodrigues Y.K.S., Amorim F.M., N\u00e9ris P.L.N., Oliveira M.R., Rodrigues-Mascarenhas S. Immunomodulatory activity of ouabain in Leishmania leishmania amazonensis-infected Swiss mice. Parasitol. Res. 2013;112:1313\u20131321. doi: 10.1007/s00436-012-3146-9.", "ArticleIdList": ["10.1007/s00436-012-3146-9", "23052777"]}, {"Citation": "Huang Y., Yang G., Fei J., Wu Y., Yan J. Bufotalin ameliorates experimental Sj\u00f6gren\u2019s syndrome development by inhibiting Th17 generation. Naunyn. Schmiedebergs. Arch. Pharmacol. 2020;393:1977\u20131985. doi: 10.1007/s00210-020-01817-1.", "ArticleIdList": ["10.1007/s00210-020-01817-1", "31950221"]}, {"Citation": "Zheng Y., Deng L., Cao H., Xu N., Zhang D., Tian H., Li B., Lu Z., Ye W., Yu L. Screening of bufadienolides from toad venom identifies gammabufotalin as a potential anti-inflammatory agent. Planta Med. 2022;88:43\u201352. doi: 10.1055/a-1248-2626.", "ArticleIdList": ["10.1055/a-1248-2626", "33049786"]}, {"Citation": "Takai N., Kira N., Ishii T., Yoshida T., Nishida M., Nishida Y., Nasu K., Narahara H. Bufalin, a traditional oriental medicine, induces apoptosis in human cancer cells. Asian Pacific J. Cancer Prev. 2012;13:399\u2013402. doi: 10.7314/APJCP.2012.13.1.399.", "ArticleIdList": ["10.7314/APJCP.2012.13.1.399", "22502710"]}, {"Citation": "Zhang Z.-J., Yang Y.-K., Wu W.-Z. Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice. J. Transl. Med. 2014;12:57. doi: 10.1186/1479-5876-12-57.", "ArticleIdList": ["10.1186/1479-5876-12-57", "PMC4015709", "24581171"]}, {"Citation": "Wu S.-H., Bau D.-T., Hsiao Y.-T., Lu K.-W., Hsia T.-C., Lien J.-C., Ko Y.-C., Hsu W.-H., Yang S.-T., Huang Y.-P., et al. Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo. Environ. Toxicol. 2017;32:1305\u20131317. doi: 10.1002/tox.22325.", "ArticleIdList": ["10.1002/tox.22325", "27444971"]}, {"Citation": "Yin P.-H., Liu X., Qiu Y.-Y., Cai J., Qin J., Zhu H.-R., Li Q. Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: New hope for cancer patients. Asian Pacific J. cancer Prev. 2012;13:5339\u20135343. doi: 10.7314/APJCP.2012.13.11.5339.", "ArticleIdList": ["10.7314/APJCP.2012.13.11.5339", "23317181"]}, {"Citation": "Karin M. NF-\u03baB as a Critical Link between Inflammation and Cancer. Cold Spring Harb. Perspect. Biol. 2009;1:a000141. doi: 10.1101/cshperspect.a000141.", "ArticleIdList": ["10.1101/cshperspect.a000141", "PMC2773649", "20066113"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "12"}, {"Year": "2022", "Month": "9", "Day": "30"}, {"Year": "2022", "Month": "9", "Day": "30"}, {"Year": "2022", "Month": "10", "Day": "14", "Hour": "2", "Minute": "27"}, {"Year": "2022", "Month": "10", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["36235123", "PMC9571018", "10.3390/molecules27196586", "molecules27196586"]}}], "PubmedBookArticle": []}